Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Apr 2022 for Theravance Biopharma, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
William d. Young: trading record in brief
William d. Young, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Praxis Precision Medicines, Inc. and Theravance Biopharma, Inc. The record holds 2 filings, for trades running from 13 May 2021 to 26 April 2022.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 28 April 2022, reports a share grant in Theravance Biopharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William d. Young
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
9,852 shares0Ordinary SharesSEC:0001415889-22-004339:0
28,473 shares0Common StockSEC:0001689548-21-000069:0
2 of 2 declarations
